Clinical Trial Update: Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of growth hormone treatment in Juvenile Idiopathic Arthritis, with completed study results on outcomes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Juvenile Idiopathic Arthritis, Still Disease, Juvenile-Onset | Phase 3 | Status: COMPLETED